Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease

Withdrawn before enrolling · Not applicable

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to determine how many patients with Parkinson's disease have compulsive behaviors, and what types of behaviors they have. This study will also determine if acamprosate can be used to treat compulsive behaviors in Parkinson's disease patients.

Key facts

Study ID

NCT00640952

Run by

Baylor College of Medicine

People needed

0

Starts

2006-08-01

Expected to finish

2008-09-01

Last updated by the study team

2015-11-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Idiopathic Parkinson's disease
• Active dopaminergic therapy at stable dose for one month (levodopa or dopamine agonist)
• Able and willing to complete Rating Scales
• Presence of one or more compulsive behavior based on responses to Rating Scales (defined as >5 on the SOGS; >17 on the YBOCS-SV and YBOCS-CUV; >1.7 on the SCS for women and >2.1 on the SCS for men; >15 on the YBOCS-BE, >5.5 on the CQ).
• Written informed consent
• Inclusion criteria (controls):
• No significant psychiatric disease
• Able and willing to complete Rating Scales
• Written informed consent

You may not qualify if…

• No anticipated need for adjustment of medications for Parkinson's disease
• Current participation in another clinical study
• History of unstable psychiatric disease (as determined by the Principal Investigator)
• Women of childbearing age not using appropriate contraceptive methods (oral contraceptives, condoms, surgery)

Where it is running

• PDCMDC 6550 Fannin, Suite 1801 — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.